Neoadjuvant QL1706 plus chemotherapy in patients with stage II-IIIB squamous non-small cell lung cancer: study protocol for a prospective, single-arm, multicentre phase II trial.
INTRODUCTION: Lung squamous cell carcinoma is a subtype of non-small cell lung cancer (NSCLC) and its biological characteristics or treatment responses might differ from non-squamous NSCLC. TRIAL REGISTRATION NUMBER: ChiCTR2500104283.
INTRODUCTION: Lung squamous cell carcinoma is a subtype of non-small cell lung cancer (NSCLC) and its biological characteristics or treatment responses might differ from non-squamous NSCLC. TRIAL REGISTRATION NUMBER: ChiCTR2500104283.
What the study was
- Study design
- Clinical Trial
- Population
- Patient/participant population (size not extracted)
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- BMJ open
Why it surfaced
Scored 8/10 (Clinical Trial; novelty=2, relevance=3, design_quality=2, population_or_unmet_need=1). HIGH priority.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.